Proliferation, Steroid Receptors and Clinical/Pathological Response in Breast Cancer Treated With Letrozole

British Journal of Cancer - United Kingdom
doi 10.1038/sj.bjc.6603001
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Nature

Related search

Steroid Hormones, Steroid Receptors, and Breast Cancer Stem Cells

Journal of Mammary Gland Biology and Neoplasia
Cancer ResearchOncology
2015English

Steroid Regulation of Breast Cancer Cell Proliferation

Breast Cancer Research
Cancer ResearchOncology
2003English

Clinical Response in Patients With Ovarian Cancer Treated With

ecancermedicalscience
Cancer ResearchOncology
2017English

ERBB-Receptors and Drug Response in Breast Cancer

1997English

Pathological Response in a Triple Negative Breast Cancer Cohort Treated With Neoadjuvant Carboplatin and Docetaxel According to Lehmann's Refined Classification

Clinical Cancer Research
Cancer ResearchOncology
2018English

A Comparison of Letrozole and Anastrozole Followed by Letrozole in Breast Cancer Patients

Breast Cancer: Targets and Therapy
Oncology
2015English

Clinical Studies of Apoptosis and Proliferation in Breast Cancer

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
1999English

Association of Pretreatment Anemia With Pathological Response and Survival of Breast Cancer Patients Treated With Neoadjuvant Chemotherapy: A Population-Based Study

PLoS ONE
Multidisciplinary
2015English

Low Residual Proliferation After Short-Term Letrozole Therapy Is an Early Predictive Marker of Response in High Proliferative ER-positive Breast Cancer

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy